AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2223344
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% EMLA cream
Trial: 2223344
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream and 1% lignocaine infiltration
Trial: 353090
Drug: Anisotropine methyl
RxNorm normalized name: Anisotropine methylbromide
DrugBank: Anisotropine methylbromide (DB00517)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anisotropine methyl bromide, 80 mg given orally at 8 P.M.
Trial: 30702534
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac potassium (50 mg)
Trial: 30702534
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen (1 g in 500 ml normal saline over 20 min)
Trial: 28826727
Drug: Drug-eluting balloon
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting balloon (DEB) with provisional bare-metal stenting
Trial: 28826727
Drug: Primary stenting
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary stenting with drug-eluting stents (DES)
Trial: 26764322
Drug: Aged Garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged Garlic Extract (AGE) 2400 mg/d
Trial: 21270270
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion on day 2
Trial: 16645371
Drug: Inhaled Nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled Nitric Oxide (iNO)
Trial: 17952474
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment without hypnosis
Trial: 11703529
Drug: Topical aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical aspirin (75 mg/mL in moisturizer, 5-10 mL, three times a day for 21 days)
Trial: 11703529
Drug: Oral aspirin
RxNorm normalized name: aspirin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aspirin (375-750 mg three times a day for 21 days)
Trial: 8005127
Drug: Oral enoximone
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enoximone (100 mg t.i.d.)
Trial: 8005127
Drug: Oral enoximone
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enoximone
Trial: 2805771
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg trazodone conventional capsules
Trial: 2805771
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg controlled‐release tablets
Trial: 2805771
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations of trazodone
Trial: 1103708
Drug: Alprenolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprenolol (200 mg twice daily)
Trial: 23880426
Drug: Iopromide 300
RxNorm normalized name: IOPROMIDE 300mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide 300 mg/ml with fixed-dose injection protocol
Trial: 23880426
Drug: Iopromide 300
RxNorm normalized name: IOPROMIDE 300mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide 300 mg/ml with body surface area adapted injection protocol
Trial: 23880426
Drug: Iopromide 370
RxNorm normalized name: IOPROMIDE 370mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide 370 mg/ml with fixed-dose injection protocol
Trial: 23880426
Drug: Iopromide 370
RxNorm normalized name: IOPROMIDE 370mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide 370 mg/ml with body surface area adapted injection protocol
Trial: 21825259
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg daily orally until disease progression (PD) occurred
Trial: 21825259
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with paclitaxel 200 mg/m2 IV and carboplatin AUC 6 IV on day 1 intercalated with erlotinib 150 mg orally on days 2 through 15 every 3 weeks for four cycles followed by erlotinib 150 mg orally until PD occurred
Trial: 14614579
Drug: Rifampicin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (600 mg daily for 5 days)
Trial: 11303851
Drug: Cefepime (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime (50 mg/kg/dose every 8 h; ≤ 6 g/day)
Trial: 11303851
Drug: Ceftazidime (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (50 mg/kg/dose every 8 h; ≤ 6 g/day)
Trial: 7605521
Drug: Prophylactic systemic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic systemic antibiotics
Trial: 3402097
Drug: Non-antibiotic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-antibiotic group
Trial: 31732485
Drug: Drug-susceptible tuberculosis
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-susceptible tuberculosis
Trial: 2526824
Drug: Acitretin 50
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin 50 mg/day
Trial: 18276652
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate 50 mg kg(‐1) i.v. as a bolus and then 15 mg kg(‐1) h(‐1) i.v. by continuous infusion
Trial: 16949484
Drug: Concordant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concordant treatment allocation
Trial: 16949484
Drug: Discordant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discordant treatment allocation
Trial: 10671664
Drug: FPLC chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPLC chemotherapy
Trial: 10671664
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no FPLC chemotherapy)
Trial: 8445428
Drug: Delayed intensification
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed intensification (Delint) phase of therapy
Trial: 8445428
Drug: Standard three-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard three-drug induction and Delint
Trial: 8445428
Drug: Intrathecal methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal methotrexate (IT MTX) during all phases of therapy
Trial: 3731891
Drug: Placebo medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo medication (group 2)
Trial: 26501498
Drug: Cognitive-behavioral conjoint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral conjoint therapy (CBCT) for PTSD
Trial: 24794367
Drug: Fluconazole (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (6 mg/kg of body weight)
Trial: 16739748
Drug: Supplemental external-beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental external-beam radiation therapy (XRT)
Trial: 14668071
Drug: Nicotine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (20 microg/kg) administered by nasal spray
Trial: 10901307
Drug: Any prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any prophylactic agent
Trial: 1519588
Drug: Prednisolone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (50 mg/day) for 1 month
Trial: 29629603
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied for 30 minutes
Trial: 9649697
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied for 60 minutes
Trial: 25168927
Drug: Prophylactic haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prophylactic haloperidol 1 mg twice daily for a maximum of seven consecutive days
Trial: 22901557
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (Omacor, 3 g/d) for 6 months
Trial: 7308331
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg in ordinary tablets
Trial: 7308331
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg in slow-release tablets
Trial: 7308331
Drug: Terbutaline (beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (beta 2-receptor stimulating agent)
Trial: 26369489
Drug: salivary substitute
RxNorm normalized name: hydroxypropyl cellulose, low substituted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salivary substitute as an adjunct to scaling and root planing (SRP)
Trial: 24372304
Drug: 3K3A-APC at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3K3A-APC at 6, 30, 90, 180, 360, 540 or 720 µg/kg
Trial: 24372304
Drug: 3K3A-APC at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3K3A-APC at 90, 180, 360, or 540 µg/kg
Trial: 21392372
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus Manual Lymphatic Drainage
Trial: 21392372
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (skin care, exercise, compression measures, bandages for one month, and compression garments)
Trial: 19711495
Drug: Culturally tailored
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally tailored cervical cancer education program in three weekly sessions
Trial: 21378155
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg daily
Trial: 10022641
Drug: Plantago ovata
RxNorm normalized name: Plantago ovata seed
DrugBank: Plantago ovata seed (DB14585)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plantago ovata seeds (10 g b.i.d.)
Trial: 10022641
Drug: Mesalamine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalamine (500 mg t.i.d.)
Trial: 10022641
Drug: Plantago ovata
RxNorm normalized name: Plantago ovata seed
DrugBank: Plantago ovata seed (DB14585)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plantago ovata seeds plus mesalamine (same doses)
Trial: 7496561
Drug: Atropine 1
RxNorm normalized name: homatropine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 1 mg (antimuscarinic)
Trial: 7496561
Drug: Nicergoline 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicergoline 2.5 mg (alpha blocker)
Trial: 7496561
Drug: Esmolol 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol 40 mg (beta 1 blocker)
Trial: 98127
Drug: Penfluridol, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penfluridol, 20 to 160 mg orally once each week
Trial: 98127
Drug: Fluphenazine decanoate,
RxNorm normalized name: FluPHENAZine Decanoate, decanoate 25 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate, 0.5 to 4 ml every two weeks
Trial: 30311042
Drug: L2 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L2 treatment (compared to L1 only)
Trial: 28361371
Drug: Beta-blocker up-titration
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Beta-blocker up-titration over 12 weeks
Trial: 17989314
Drug: Immunosuppressive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive therapy (IST) - second course
Trial: 12882864
Drug: AC2993 (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC2993 (0.08 micro g/kg)
Trial: 11077932
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate (177 mg/kg/day in three divided doses equivalent to 40 mg elemental zinc)
Trial: 28849265
Drug: Intraoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative chemotherapy
Trial: 6209506
Drug: Propranolol, 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 160 mg (single oral dose)
Trial: 25318980
Drug: Routine health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine health education offered monthly by health staff at health facilities
Trial: 19332196
Drug: High-dose simvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose simvastatin (80 mg)
Trial: 10335764
Drug: Low-dose simvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose simvastatin (40 mg)
Trial: 10335764
Drug: High-dose atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose atorvastatin (40 mg)
Trial: 8935744
Drug: Thiamine hydrochloride
RxNorm normalized name: Thiamine Hydrochloride
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiamine hydrochloride (vitamin B1) 100 mg orally, daily for 90 days
Trial: 31401973
Drug: 7.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg/kg rabbit ATG
Trial: 31401973
Drug: 10.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.0 mg/kg rabbit ATG
Trial: 22578975
Drug: Easy separation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Easy separation from CPB (no support or one vasoactive agent/inotrope)
Trial: 22578975
Drug: Difficult separation
RxNorm normalized name: Clostridioides difficile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Difficult separation from CPB (two drug types used)
Trial: 19507027
Drug: Enteric-coated, delayed-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated, delayed-release peppermint oil (Colpermin)
Trial: 760589
Drug: Oral oxazepam
RxNorm normalized name: Oxazepam
DrugBank: Oxazepam acetate (DB14672)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral oxazepam
Trial: 25772548
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg as add-on to sulphonylurea
Trial: 25772548
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg as add-on to sulphonylurea
Trial: 25772548
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg as add-on to other therapies
Trial: 25772548
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg as add-on to other therapies
Trial: 23369827
Drug: Ferric citrate
RxNorm normalized name: Ferric Citrate
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric citrate 1 g/d
Trial: 23369827
Drug: Ferric citrate
RxNorm normalized name: Ferric Citrate
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric citrate 6 g/d
Trial: 23369827
Drug: Ferric citrate
RxNorm normalized name: Ferric Citrate
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric citrate 8 g/d
Trial: 24102165
Drug: Sham laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham laser treatment (control group)
Trial: 1730427
Drug: Oral melphalan
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral melphalan
Trial: 29748907
Drug: Alfacalcidol (VDRA)
RxNorm normalized name: alfacalcidol
DrugBank: Alfacalcidol (DB01436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol (VDRA) 0.25-0.5 µg once a day
Trial: 29748907
Drug: Alfacalcidol (VDRA)
RxNorm normalized name: alfacalcidol
DrugBank: Alfacalcidol (DB01436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol (VDRA) 0.25-0.5 µg once a day + Lanthanum carbonate (LC) 250 mg once a day
Trial: 24670828
Drug: Drug Eluting
RxNorm normalized name: Drug eluting stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Eluting Balloon (DEB)
Trial: 22452942
Drug: Granisetron transdermal
RxNorm normalized name: Granisetron Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron transdermal system (GTDS)
Trial: 8845475
Drug: Intravenous granisetron
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous granisetron
Trial: 22452942
Drug: Oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral moxifloxacin (active control)
Trial: 16949264
Drug: Formoterol twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol twice daily (3.45% asthma exacerbations; 6 of 174 patients)
Trial: 16949264
Drug: Formoterol twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol twice daily supplemented by salbutamol
Trial: 9667590
Drug: Interferon-beta1b (IFN-beta1b)
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-beta1b (IFN-beta1b) in combination with pentoxifylline (PTX)
Trial: 8537138
Drug: Cefixime 8
RxNorm normalized name: cefixime 8 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 8 mg/kg body weight once daily for 5 days
Trial: 30508156
Drug: Quality of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quality of life scores during the entire treatment period
Trial: 28704520
Drug: Self-affirmation exercise
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-affirmation exercise with correcting information about MMR vaccine and autism
Trial: 28704520
Drug: Control passage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control passage about bird feeding with correcting information about MMR vaccine and autism
Trial: 23247973
Drug: Control cohort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control cohort receiving no drug treatment
Trial: 17109685
Drug: Talpha1 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Talpha1 therapy (1.6 mg, two times a week for 26 weeks)
Trial: 17109685
Drug: Talpha1 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Talpha1 therapy (1.6 mg, two times a week for 52 weeks)
Trial: 17109685
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no specific treatment for 18 months)
Trial: 14606705
Drug: Talpha1 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Talpha1 therapy
Trial: 11789123
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of St. John's wort extract WS 5572 daily
Trial: 11789123
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg of St. John's wort extract WS 5572 daily
Trial: 9247843
Drug: Homoeopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homoeopathic treatment (Aconitum napellus, Apis mellifica, Belladonna, Capsicum, Chamomilla, Kalium bichromicum, Lachesis, Lycopodium, Mercurius solubilis, Okoubaka, Pulsatilla, Silicea)
Trial: 9247843
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (nasal drops, antibiotics, secretolytics and/or antipyretics)
Trial: 19828937
Drug: Homoeopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homoeopathic treatment
Trial: 7967986
Drug: Daily training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily training
Trial: 3583229
Drug: Aspirin (330
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (330 mg) and dipyridamole (75 mg) taken three times daily for three weeks
Trial: 17177154
Drug: Intramuscular interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular interferon beta‐1a 15 micrograms once a week
Trial: 17177154
Drug: No disease-modifying
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No disease-modifying therapy
Trial: 10972697
Drug: Epoetin alpha
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alpha to achieve hemoglobin levels of 10 g/dL